Germany Transcatheter Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Transcatheter Embolization & Occlusion Devices, and Transcatheter Replacement Devices), By Application (Cardiovascular and Oncology), and Germany Transcatheter Devices Market Insights, Industry Trend, Forecasts to 2035

 Germany Transcatheter Devices Market Insights Forecasts to 2035

• The Germany Transcatheter Devices Market Size Was Estimated at USD 647.65 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.51% from 2025 to 2035
• The Germany Transcatheter Devices Market Size is Expected to Reach USD 1759.78 Million by 2035

According to a research report published by Spherical Insights & Consulting, The Germany Transcatheter Devices Market Size is anticipated to reach USD 1759.78 Million by 2035, Growing at a CAGR of 9.51% from 2025 to 2035. Market's expansion is the rising demand for minimally invasive procedures and surgeries, or MIS. Comparing these procedures to invasive ones like open heart operations, the patient has less trauma and recovers more quickly. MIS improves patient outcomes and economic feasibility from both a local and macro level by reducing the need for hospital stays.

Market Overview

The market for surgical equipment that is used for minimally invasive procedures such as those in cardiovascular and other therapeutic fields falls under the field of transcatheter devices. Devices such as stents, valves, and embolization devices are potential less invasive alternatives to open surgeries that are administered via catheter to treat a range of conditions. The current trends driving the market are, the increasing prevalence of chronic diseases, innovative advances in minimally invasive technologies, and a growing patient preference for surgery that carries less risk and faster recovery method. Transcatheter procedures involve smaller incisions and, as a result, may reduce post-operative discomfort as well as stress on the body. Smaller incisions and less manipulation of the tissue in comparison to open surgery also aid in decreasing the chance of infection. For patients and their care providers seeking less invasive procedures devoid of high-risk factors in addition to a quicker recovery period, transcatheter devices offer a suitable non-invasive alternative to traditional open and closed-heart surgery. The programs essentially reduce reliance on imports while promoting the development of non-invasive surgical devices, particularly transcatheter devices, thereby allowing greater device access and availability.

Report Coverage

This research report categorizes the market for Germany transcatheter devices market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany transcatheter devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment Germany transcatheter devices market.

Driving Factors        

The rising prevalence of cardiovascular disease, greater attractiveness of minimally invasive procedures, and advancements in device technology are contributing to this increase. The aging population and increased spending on healthcare are also driving increased demand. Technological advances in catheter design and imaging guidance to improve success rates of procedures also support this increase. Lastly, the expanding use in oncology and structural heart procedures is supporting market growth.

Restraining Factors

The high costs associated with devices and procedures limit access, particularly in developing regions where there is less reimbursement. Strict regulatory pathways and protracted clinical trials can additionally slow product launch timelines and raise development costs. Risks of device failure, thrombosis, and anatomical outfitting may lead to complications following a procedure and can impact clinician and/or patient confidence.

Market Segmentation

The Germany transcatheter devices market share is classified into product and application.

• The transcatheter embolization & occlusion devices segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany transcatheter devices market is segmented by product into transcatheter embolization & occlusion devices, and transcatheter replacement devices. Among these, the transcatheter embolization & occlusion devices segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. A less invasive option to conventional surgical valve replacements is provided by transcatheter replacement devices. Patients and healthcare professionals find these operations appealing due to their faster recovery times, shorter hospital stays, and decreased incidence of complications. It is anticipated that ongoing technical developments and a rise in product releases by industry participants will sustain market expansion.

• The cardiovascular segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Germany transcatheter devices market is segmented by application into cardiovascular and oncology. Among these, the cardiovascular segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising prevalence of heart diseases, the aging population, and the increased adoption of minimally invasive procedures. Advancements in transcatheter technologies, such as TAVR and mitral valve repair, further drive demand. Growing awareness and improved healthcare infrastructure also contribute to its strong growth in Germany.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany transcatheter devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies       

• Biotronik
• Jenavalve Technology
• CoreMedic GmbH
• InnoRa GmbH
• Transcatheter Technologies GmbH
• MagForce AG
• Karl Storz SE & Co. KG
• Maquet GmbH
• Brainlab SE
• Freudenberg Medical
• Lohmann & Rauscher
• Staiger GmbH
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Germany transcatheter devices market based on the below-mentioned segments:

Germany Transcatheter Devices Market, By Product

• Transcatheter Embolization & Occlusion Devices
• Transcatheter Replacement Devices

Germany Transcatheter Devices Market, By Application

• Cardiovascular
• Oncology